Voor zorgverleners

The story of the Beta Cells and their role in autoimmune Type 1 Diabetes

A Beta way - Type 1 diabetes

Influenza can wreak havoc across major organ systems

An unpredictable virus with a devastating impact on patients’ lives^1-3,5

EVEREST study highlights

First ever direct Head-to-Head Comparison of Dupilumab vs Omalizumab in Patients with Severe CRSwNP and Coexisting Asthma.

Understanding Disease Modification in Atopic Dermatitis

Act early, think holistically for your patients with Type 2 diabetes at very high cardiovascular risk

People with type 2 diabetes and atherosclerotic cardiovascular disease face a high risk of cardiovascular events, yet many remain undertreated.¹ The EASD/ADA 2022 and ESC 2023 guidelines for the management of type 2 diabetes urge early insulin initiation and intensive lipid lowering through a holistic approach. Managing both glycemia and lipids together is key to preventing CV events in people with type 2 diabetes.^2,3

Understanding Autoimmune T1D & The Value of Early Detection

Autoimmune Type 1 Diabetes (T1D) can be detected through islet autoantibody testing years before symptoms appear.^1-2 The video here explains how the condition progresses silently through presymptomatic stages, with beta cell destruction occurring long before symptom onset and clinical diagnosis.^4-8

When a Child Gets Autoimmune Type 1 Diabetes

Parent's experiences of stage 3 diagnosis of T1D.

Sleep and QOL: the full impact on patients coping with the burden of AD

Understanding the full scope of AD—the unseen burden on patients.

Can autoimmune type 1 diabetes be detected years before symptom onset?

Autoimmune type 1 diabetes (T1D) is a progressive disease in which the decline in beta cell function usually begins months or sometimes years before clinical symptoms are observed.^1–3 You can identify such patients at risk of developing autoimmune T1D before clinical symptoms are noticed by you or your patient.³